Related Experiment Videos
Silent myocardial ischemia. Answers to frequently asked questions
1Department of Medicine, Medical University of South Carolina, Charleston 29425.
Insights
Screening for silent myocardial ischemia is recommended for middle-aged men with multiple coronary artery disease risk factors. Radionuclear imaging aids risk identification, guiding treatment strategies beyond symptom relief for better patient outcomes.
Area of Science:
- Cardiology
- Preventive Cardiology
- Diagnostic Imaging
Background:
- Coronary artery disease (CAD) patients with silent myocardial ischemia share similar prognoses to symptomatic individuals.
- Screening asymptomatic individuals broadly is unlikely to detect many cases of silent ischemia.
- Certain high-risk cohorts, such as middle-aged men with multiple cardiovascular risk factors, may benefit from targeted screening.
Purpose of the Study:
- To evaluate the efficacy of screening for silent myocardial ischemia in specific patient populations.
- To identify high-risk individuals who could benefit from further cardiac evaluation and intervention.
- To discuss optimal treatment strategies for silent myocardial ischemia.
Main Methods:
- Utilizing radionuclear imaging techniques during exercise stress testing to identify high-risk patients.
- Coronary arteriography as a diagnostic tool for patients identified as high-risk.
- Ambulatory electrocardiographic monitoring for individualizing anti-ischemic therapy.
Main Results:
- Radionuclear imaging during stress testing is effective in identifying patients at high risk for adverse cardiac events.
- Screening is advised for specific cohorts, including middle-aged men with multiple coronary arteriosclerosis risk factors.
- A treatment strategy solely based on symptom relief is suboptimal for managing silent ischemia.
Conclusions:
- Targeted screening for silent myocardial ischemia in high-risk men is warranted.
- Radionuclear imaging aids in identifying patients who may benefit from coronary arteriography.
- Individualized treatment, potentially guided by ambulatory monitoring, is crucial for managing silent ischemia effectively.
Abstract:
Patients with coronary artery disease and silent myocardial ischemia have a prognosis similar to that of symptomatic patients. Screening of totally asymptomatic patients is not likely to identify many with silent ischemia. However, certain cohorts of patients--middle-aged men with two or more risk factors for coronary arteriosclerosis--are at risk of presenting initially with myocardial infarction or sudden death, and the screening of such persons is advised. Use of radionuclear imaging techniques during exercise stress testing appears to be helpful in identifying patients at high risk, who should then be offered coronary arteriography. An ideal treatment has not been established, but a treatment strategy based on symptom relief alone is suboptimal. Measures used for symptomatic ischemia are just as effective with silent ischemia. Treatment must be individualized, and ambulatory electrocardiographic monitoring appears useful in adjusting antiischemic therapy for a given patient.